» Pharmaceutical Industry Full Coverage Main Page

Pharmaceutical Industry: News Stories

FDA to Suspend a Rule On Child Drug Testing - at Washington Post - Tue, Mar 19, 2002
First Antiviral Common-Cold Drug Faces Key Ruling - at Washington Post - Sat, Mar 16, 2002
Corixa turned back by FDA - at Seattle Times - Thu, Mar 14, 2002
Corixa hits new roadblock - at Seattle Post-Intelligencer - Thu, Mar 14, 2002
ZymoGenetics posts a $37 million loss - at Seattle Post-Intelligencer - Tue, Mar 12, 2002
Pharmacy Chains to Simplify Drugmakers' Discount Cards - at Washington Post - Tue, Mar 12, 2002
ZymoGenetics patent lawsuit hits at key time - at Seattle Times - Mon, Mar 11, 2002
Claritin To Be Sold Over the Counter - at Washington Post - Sat, Mar 09, 2002
ZymoGenetics sues Immunex for patent violation - at Seattle Post-Intelligencer - Fri, Mar 08, 2002
Biotechs battle as ZymoGenetics sues Immunex over drug Enbrel - at Seattle Times - Fri, Mar 08, 2002
Deal to Boost Drug Approval, Oversight - at Washington Post - Thu, Mar 07, 2002
ImClone, Bristol Revise Deal on Cancer Drug - at Washington Post - Wed, Mar 06, 2002
Elan abandons further trials on experimental Alzheimer's vaccine - at Irish Times - Sat, Mar 02, 2002
Enbrel rival builds steam as FDA OKs claim that drug improves function - at Seattle Times - Fri, Mar 01, 2002
New insights into AIDS link to pill - at Seattle Times - Thu, Feb 28, 2002
Pharmacist admits diluting drugs - at USA TODAY - Wed, Feb 27, 2002
Prescription Drug Proposal Spurs Bidding - at Washington Post - Tue, Feb 26, 2002
Immunex touts effectiveness of arthritis drug Enbrel in treating psoriasis - at Seattle Times - Fri, Feb 22, 2002
Cell Therapeutics has sales letdown as cancer drug's first full market year falls short - at Seattle Times - Thu, Feb 21, 2002
Corixa rival Idec Pharmaceuticals gets OK for cancer drug - at Seattle Times - Wed, Feb 20, 2002
FDA headache: balancing safety and drug approval - at Seattle Times - Tue, Feb 19, 2002
Immunex's Enbrel tied to lupus in four patients - at Seattle Times - Fri, Feb 15, 2002
Glaxo's post-merger profit rises 13% - at Philadelphia Inquirer - Fri, Feb 15, 2002
Drug Marketers Focus on Doctors - at Washington Post - Thu, Feb 14, 2002
ImClone refuses to alter $2B deal - at USA TODAY - Wed, Feb 13, 2002
Dot.com chemists who put lives at risk - at The Guardian (UK). - Mon, Feb 11, 2002
Botox to be approved for cosmetic purposes - at CNN - Thu, Feb 07, 2002
Scientists take money for ghostwritten papers - at The Guardian (UK). - Thu, Feb 07, 2002
'It said the drug was the best thing since sliced bread. I don't think it is' - at The Guardian (UK). - Thu, Feb 07, 2002
'Ghostwritten' research claims - at BBC - Thu, Feb 07, 2002
Elan used Bermuda connection to raise $950m - at The Guardian (UK). - Wed, Feb 06, 2002
Debt revelations hit Elan - at The Guardian (UK). - Tue, Feb 05, 2002
Pfizer to Stop Working on GenVec Heart Drug - at Washington Post - Fri, Jan 25, 2002
Drug Firms Still Lavish Pricey Gifts On Doctors - at Washington Post - Sat, Jan 19, 2002
Anti-smoking drug deaths triple - at BBC - Fri, Jan 18, 2002
Online Cipro Crackdown Won't Be The Last - Washington AG - at NewsBytes - Tue, Jan 15, 2002
Drug firm loses fair trading appeal - at BBC - Tue, Jan 15, 2002
Igen Wins Suit Against Roche - at Washington Post - Fri, Jan 11, 2002
Plane Crash Revives Accutane Questions - at Washington Post - Fri, Jan 11, 2002
Lawsuits say movies 'based' on real events often distort them, damaging reputations of real participants - at USA TODAY - Tue, Jan 08, 2002
Husband and wife team share biotech bonanza - at The Guardian (UK). - Mon, Jan 07, 2002
Anti-colorectal cancer drug faces FDA obstacle - at USA TODAY - Fri, Jan 04, 2002
GAO Tests Value of Drug Discount Cards - at Washington Post - Fri, Jan 04, 2002
Low Fliers Behind the Drugs - at Washington Post - Thu, Jan 03, 2002
U.S. Says It Bought Radiation Drug - at Washington Post - Thu, Jan 03, 2002
Record biotech merger announced - at BBC - Mon, Dec 17, 2001
Amgen agrees to buy Immunex for $16bn - at Financial Times - Mon, Dec 17, 2001
Amgen to buy Immunex in $16 billion deal - at CBS MarketWatch (registration req'd) - Mon, Dec 17, 2001
Millennium man - at Boston Globe - Wed, Dec 12, 2001
'Shortcut' could slash drug costs - at BBC - Wed, Dec 12, 2001

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Next

Primary Navigation

Secondary Navigation

Pharmaceutical Industry: News Stories

More

Primary Navigation